Development Of Recombinant Rsolcd39-Psgl As A Novel Therapeutic With Anti-Thrombotic And Anti-Inflammatory Effects

Abstract

Heart disease and stroke are due to a narrowing of arteries followed by occlusion, due a combination of clot formation initiated by platelet clumping, and inflammation surrounding the vessel wall. The currently available drugs are often limited by the adverse reaction of bleeding. We will investigate the efficiency of a new drug to prevent clot formation and inflammation.